Comorbidity in patients with diabetes mellitus: impact on medical health care utilization

BackgroundComorbidity has been shown to intensify health care utilization and to increase medical care costs for patients with diabetes. However, most studies have been focused on one health care service, mainly hospital care, or limited their analyses to one additional comorbid disease, or the data were based on self-reported questionnaires instead of health care registration data. The purpose of this study is to estimate the effects a broad spectrum of of comorbidities on the type and volume of medical health care utilization of patients with diabetes.MethodsBy linking general practice and hospital based registrations in the Netherlands, data on comorbidity and health care utilization of patients with diabetes (n = 7,499) were obtained. Comorbidity was defined as diabetes-related comorbiiabetes-related comorbidity. Multilevel regression analyses were applied to estimate the effects of comorbidity on health care utilization.ResultsOur results show that both diabetes-related and non diabetes-related comorbidity increase the use of medical care substantially in patients with diabetes. Having both diabeterelated and non diabetes-related comorbidity incrases the demand for health care even more. Differences in health care utilization patterns were observed between the comorbidities.ConclusionNon diabetes-related comorbidity increases the health care demand as much as diabetes-related comorbidity. Current single-disease approach of integrated diabetes care should be extended with additional care modules, which must be generic and include multiple diseases in order to meet the complex health care demands of patients with diabetes in the future.

[1]  J. O'brien,et al.  Direct Medical Costs of Complications Resulting From Type 2 Diabetes in Hie U.S. , 1998, Diabetes Care.

[2]  S. A. Black Increased health burden associated with comorbid depression in older diabetic Mexican Americans. Results from the Hispanic Established Population for the Epidemiologic Study of the Elderly survey. , 1999, Diabetes care.

[3]  John S Yudkin,et al.  Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study , 2000, BMJ : British Medical Journal.

[4]  M. Hanefeld,et al.  Diabetes Intervention Study: Multi-Intervention Trial in Newly Diagnosed NIDDM , 1991, Diabetes Care.

[5]  Antonio Godoy Clinical judgement. , 1985, The Journal of the Royal College of General Practitioners.

[6]  Philip Jacobs,et al.  The cost of major comorbidity in people with diabetes mellitus. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[7]  François G Schellevis,et al.  Comorbidity and guidelines: conflicting interests , 2006, The Lancet.

[8]  G. Olveira,et al.  Increased hospital expenditures in diabetic patients hospitalized for cardiovascular diseases. , 2003, Journal of diabetes and its complications.

[9]  H. Lamberts,et al.  The Internatinal classification of primary care in the European community : multi-language layer , 1993 .

[10]  W. Satariano,et al.  Patterns of comorbidity and the use of health services in the Dutch population. , 2001, European journal of public health.

[11]  W. Satariano,et al.  Causes and consequences of comorbidity: a review. , 2001, Journal of clinical epidemiology.

[12]  J. B. Reitsma Registers in cardiovascular epidemiology , 1999 .

[13]  B. Scherstén,et al.  Cost of illness of adult diabetes mellitus underestimated if comorbidity is not considered , 2001, Journal of internal medicine.

[14]  J. Avorn,et al.  Variability in length of hospitalization for stroke. The role of managed care in an elderly population. , 1996, Archives of neurology.

[15]  H. Boshuizen,et al.  Comorbidity in patients with rheumatoid arthritis: effect on health-related quality of life. , 2004, The Journal of rheumatology.

[16]  Peter Libby,et al.  Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. , 2002, JAMA.

[17]  Morton B. Brown,et al.  The direct medical cost of type 2 diabetes. , 2003, Diabetes care.

[18]  J. Bensing,et al.  Monitoring health inequalities through general practice: the Second Dutch National Survey of General Practice. , 2005, European journal of public health.

[19]  J A Knottnerus,et al.  Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. , 1998, Journal of clinical epidemiology.

[20]  Stephen J. Aldington,et al.  UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis , 2001, Diabetologia.

[21]  J. Rapoport,et al.  Refining the measurement of the economic burden of chronic diseases in Canada. , 2004, Chronic diseases in Canada.

[22]  Adaline C. Hayden,et al.  Classification of Diseases , 1896, The Dental register.

[23]  K. Freedland,et al.  The prevalence of comorbid depression in adults with diabetes: a meta-analysis. , 2001, Diabetes care.

[24]  M. Pringle,et al.  The International Classification of Primary Care in the European Community , 1994 .

[25]  L. Egede,et al.  Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. , 2002, Diabetes care.

[26]  M. Battersby Health reform through coordinated care: SA HealthPlus , 2005, BMJ : British Medical Journal.